Maravai Lifesciences Holdings Inc Cl A (NQ: MRVI )

4.885 -2.955 (-37.69%)

Streaming Delayed Price Updated: 11:23 AM EST, Nov 8, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Maravai Lifesciences Holdings Inc Cl A

< Previous 1 2 3 4 5 6 7 8 Next >

I-Mab Stock Flashes Vital Signs With 89 RS Rating

September 01, 2021

I-Mab stock had its Relative Strength Rating upgraded from 70 to 89 on Wednesday. Is this biopharma stock on your radar?

Via Investor's Business Daily

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal

August 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...

Via Benzinga

Exposures Product Safety

Maravai LifeSciences - Pick Of The Day

August 21, 2021

Healthcare company Maravai's stock hit 18 new highs and is up 51.06% in the last month.

Via Talk Markets

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Exposures Product Safety

Earnings Scheduled For August 10, 2021

August 10, 2021

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Exposures Product Safety

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Stocks That Hit 52-Week Highs On Monday

August 23, 2021

Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG...

Via Benzinga

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

August 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Genmab Stock Flashes Healthy RS Rating

August 18, 2021

Genmab stock just cleared an important benchmark with an RS Rating upgrade from 79 to 82. Is Genmab on your watchlist?

Via Investor's Business Daily

Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; Virpax Pharmaceuticals Shares Spike Higher

August 17, 2021

Toward the end of trading Tuesday, the Dow traded down 1.18% to 35,204.03 while the NASDAQ fell 1.24% to 14,610.77. The S&P also fell, dropping 1.06% to 4,432.01. The U.S. has...

Via Benzinga

Topics Stocks

Exposures US Equities

Stock Market Near Highs, Treasury Yields Rally; Disney, Several IPOs Jump On Earnings

August 13, 2021

Stocks traded at highs this week despite some growth wobbles. Treasury yields rebounded. Disney and some IPOs jumped on earnings.

Via Investor's Business Daily

Topics Stocks

Exposures US Equities

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

Exposures Product Safety

Arcturus Stock, A Covid Play, Flashes Vital Signs

August 11, 2021

A Relative Strength Rating upgrade for Alcobra shows improving technical performance.

Via Investor's Business Daily

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2021 Earnings Call Transcript

August 10, 2021

MRVI earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Exposures Financial

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

Exposures COVID-19

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

Exposures Product Safety

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

Biotech Maravai LifeSciences Sees RS Rating Rise To 89

August 04, 2021

Maravai Lifesciences shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 89.

Via Investor's Business Daily

Topics Initial Public Offering

Exposures Securities Market

Maravai Lifesciences Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating

July 23, 2021

Maravai Lifesciences sees its Relative Strength Rating enter the 80-plus level.

Via Investor's Business Daily

Editas Medicine Stock Shows Improved Relative Strength Rating

July 22, 2021

A Relative Strength Rating upgrade for Editas Medicine shows improving technical performance. Will it continue?

Via Investor's Business Daily

Codex DNA Shares Move Higher On Licensing, Supply Deal With TriLink For mRNA Capping Tech

July 21, 2021

Codex DNA Inc (NASDAQ: DNAY) has announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences Holdings Inc...

Via Benzinga

BridgeBio Pharma Stock Sees Rising Relative Strength; Still Shy Of Key Threshold

July 01, 2021

In a welcome move, biotech BridgeBio Pharma stock saw its Relative Strength Rating rise from 70 to 73 on Thursday.

Via Investor's Business Daily

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Translate Bio Stock Sees Relative Strength Rating Jump To 88

June 30, 2021

A Relative Strength Rating upgrade for Translate Bio shows improving technical performance.

Via Investor's Business Daily

Translate Bio Stock Flashes Improved Technical Strength Rating; Triple-Digit Sales Growth

June 28, 2021

Translate Bio shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Crispr Therapeutics Stock Sees Improved Relative Strength Rating

June 25, 2021

Crispr Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 68 to 74.

Via Investor's Business Daily

Novan Stock Joins Elite Club Of Stocks With RS Ratings Over 90

June 14, 2021

Novan shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Twist Bioscience Stock Hits 80-Plus Relative Strength Rating Benchmark

June 11, 2021

TwistBioscienceCorp shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.

Via Investor's Business Daily

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda

June 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Penticton Herald

Penticton Herald

Maravai Lifesciences Holdings Inc Cl A (NQ: MRVI )

All News about Maravai Lifesciences Holdings Inc Cl A

Contact us

Sections

Services

Search